ResearchMoz

Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalData
Published Date » 2012-09-30
No. Of Pages » 149
     
  Renal Dialysis Equipment Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018  
   
 GlobalDatas new report, Renal Dialysis Equipment Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global renal dialysis equipment market. The report provides market landscape, competitive landscape and market trends information on the renal dialysis equipment market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. 
   
 This report is built using data and information sourced from proprietary databases, primary and secondary...
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 8

2 Introduction 10
2.1 GlobalData Report Guidance 10

3 Disease Overview - Renal Failure 11
3.1 Introduction 11
3.2 Types of Renal Failure 11
3.2.1 Classification of CRF 12
3.2.2 Risk Factors for CRF 13
3.2.3 Signs and Symptoms of CRF 14
3.2.4 Complications of CRF 15
3.2.5 Co-Morbid Conditions 15
3.3 ESRD 17
3.3.1 Causes of ESRD 17
3.4 Epidemiology of CRF and ESRD: Patient Numbers, Prevalence, Incidence, and Mortality Rate 18
3.4.1 Global 18
3.4.2 US 21
3.4.3 Canada 22
3.4.4 Europe 22
3.4.5 Asia and Australia 23
3.5 Treatment Options 24

4 Device-Based Treatment Modalities - Dialysis 25
4.1.1 Dialysis Machine 27
4.1.2 Types of Dialysis 27

5 Renal Dialysis Equipment - Global Market Characterization 37
5.1 Global Renal Dialysis Equipment Market, Revenue ($bn), Historic, 2004-2011 37
5.2 Global Renal Dialysis Equipment Market, Revenue ($bn), Forecast, 2011-2018 38
5.3 Global Renal Dialysis Equipment Market, Key Trends 39
5.3.1 Home-Based Dialysis is Becoming a New Paradigm for ESRD Patients, Thus Expanding Patient Options 39
5.3.2 Wearable, Portable Dialysis Machines are the Latest Technology Trend 43
5.4 Global Renal Dialysis Equipment Market Dynamics 44
5.4.1 Market Drivers 45
5.4.2 Restraints 53

6 Renal Dialysis Equipment Market - Segment Analysis 58
6.1 Hemodialysis Machines 59
6.1.1 Global Hemodialysis Machines Market, Revenue ($m), Historic, 2004-2011 59
6.1.2 Global Hemodialysis Machines Market, Revenue ($m), Forecast, 2011-2018 60
6.1.3 Hemodialysis Machines, Market Dynamics 61
6.2 Peritoneal Dialysis Solutions 63
6.2.1 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Historic, 2004-2011 63
6.2.2 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Forecast, 2011-2018 64
6.2.3 Peritoneal Dialysis Solutions, Market Dynamics 65
6.2.4 Market Restraints 67
6.3 Continuous Renal Replacement Therapy (CRRT) Machines 69
6.3.1 Continuous Venovenous Hemofiltration (CVVH) 69
6.3.2 Continuous Venovenous Hemodiafiltration (CVVHDF) 69
6.3.3 Continuous Venovenous Hemodialysis (CVVHD) 70
6.3.4 Slow, Continuous Ultrafiltration (SCUF) 70
6.3.5 Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), Historic, 2004-2011 70
6.3.6 Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), Forecast, 2011-2018 71
6.3.7 Continuous Renal Replacement Therapy, Market Dynamics 72
6.4 Dialysis Accessories 73
6.4.1 AV Fistula Needles 73
6.4.2 Blood Tubing Sets 73
6.4.3 Dialysis Catheters 73
6.4.4 Dialyzers 73
6.4.5 Global Dialysis Accessories Market, Revenue ($m), Historic, 2004-2011 73
6.4.6 Global Dialysis Accessories Market, Revenue ($m), Forecast, 2011-2018 74
6.4.7 Dialysis Accessories, Market Dynamics 75

7 Renal Dialysis Equipment Market by Country, Revenue ($m), 2004 - 2018 77
7.1 Renal Dialysis Equipment Market, The US, Revenue ($m), Historic, 2004-2011 77
7.2 Renal Dialysis Equipment Market, The US, Revenue ($m), Forecast, 2011-2018 78
7.3 Renal Dialysis Equipment Market, Canada, Revenue ($m), Historic, 2004-2011 80
7.4 Renal Dialysis Equipment Market, Canada, Revenue ($m), Forecast, 2011-2018 81
7.5 Renal Dialysis Equipment Market, The UK, Revenue ($m), Historic, 2004-2011 82
7.6 Renal Dialysis Equipment Market, The UK, Revenue ($m), Forecast, 2011-2018 84
7.7 Renal Dialysis Equipment Market, Germany, Revenue ($m), Historic, 2004-2011 85
7.8 Renal Dialysis Equipment Market, Germany, Revenue ($m), Forecast, 2011-2018 86
7.9 Renal Dialysis Equipment Market, France, Revenue ($m), Historic, 2004-2011 87
7.10 Renal Dialysis Equipment Market, France, Revenue ($m), Forecast, 2011-2018 88
7.11 Renal Dialysis Equipment Market, Italy, Revenue ($m), Historic, 2004-2011 89
7.12 Renal Dialysis Equipment Market, Italy, Revenue ($m), Forecast, 2011-2018 90
7.13 Renal Dialysis Equipment Market, Spain, Revenue ($m), Historic, 2004-2011 91
7.14 Renal Dialysis Equipment Market, Spain, Revenue ($m), Forecast, 2011-2018 92
7.15 Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
7.16 Renal Dialysis Equipment Market, Japan, Revenue ($m), Forecast, 2011-2018 94
7.17 Renal Dialysis Equipment Market, China, Revenue ($m), Historic, 2004-2011 95
7.18 Renal Dialysis Equipment Market, China, Revenue ($m), Forecast, 2011-2018 97
7.19 Renal Dialysis Equipment Market, India, Revenue ($m), Historic, 2004-2011 98
7.20 Renal Dialysis Equipment Market, India, Revenue ($m), Forecast, 2011-2018 99
7.21 Renal Dialysis Equipment Market, Australia, Revenue ($m), Historic, 2004-2011 100
7.22 Renal Dialysis Equipment Market, Australia, Revenue ($m), Forecast, 2011-2018 101
7.23 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Historic, 2004-2011 102
7.24 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Forecast, 2011-2018 104

8 Global Renal Dialysis Equipment Market - Strategic Competitive Assessment 105
8.1 Renal Dialysis Equipment Market, Global, Company Share (%), 2011 105
8.2 Market Opportunities and Risks 106
8.3 Key Market Participants 107
8.3.1 Fresenius Medical Care 107
8.3.2 Baxter International 110
8.3.3 Gambro 112
8.3.4 B. Braun Melsungen 115
8.3.5 Nipro Corporation 116

9 Global Renal Dialysis Equipment Market - Strategic Pipeline Assessment 118
9.1 Pipeline Assessment by Development Stage, 2012 118
9.2 Pipeline Products Summary 118
9.3 Profiles of Key Hemodialysis Machines and Equipment in Clinical Development 119
9.3.1 AFE System 119
9.3.2 Ambulatory Wearable Device 119
9.3.3 Blood Purification Technologies Wearable Artificial Kidney 120
9.3.4 Hemova Port Device 120
9.3.5 Lifeline TEBV - AV Shunt 121
9.3.6 Neutrolin 121
9.3.7 Nocturnal Home Hemodialysis System 122
9.3.8 Optiflow Vascular Anastomotic System 122
9.3.9 Pediatric Renal Dialysis Machine 123
9.3.10 Phraxis InterGraft 123
9.3.11 Prolong AV Graft 124
9.3.12 SelfCare+ 124
9.3.13 Theralite 125
9.3.14 Thixotropic Gel 125
9.3.15 Peritoneal Dialysis Equipment and Accessories, Pipeline Products Summary 126
9.4 Profiles of Key Peritoneal Dialysis Equipment and Accessories Under Clinical Development 126
9.4.1 AWAK 126
9.4.2 Non PVC CAPD 127
9.4.3 Renal Expres 127
9.4.4 Dialysis Accessories, Pipeline Products Summary 128
9.5 Profiles of Key Dialysis Accessories Under Clinical Development 129
9.5.1 Artificial Hemodialysis Access Graft 129
9.5.2 ASPIRE Hemodialysis 129
9.5.3 Biologic Vascular Graft 129
9.5.4 ClearGuard HD 130
9.5.5 CMA 107 Microdialysis Pump 130
9.5.6 CreatiVasc Hemoaccess Valve System 131
9.5.7 dCELL Arterial-Vascular Graft 131
9.5.8 NexSite Hemodialysis Catheter 132
9.5.9 Percutaneous Implant Tool 132
9.5.10 Renaflo II Hemofilter 133
9.5.11 Reversus Hemodialysis Catheter 133
9.5.12 Selective Cytopheretic Device 134
9.5.13 SAFETOUCH AVF Needle 134
9.5.14 Venous Window Needle Guide 135

10 Global Renal Dialysis Equipment Market - Strategic Deal Analysis 136
10.1 Mergers and Acquisitions, 2008-2012 136
10.1.1 Shandong Weigao Group Forms Joint Venture with Terumo Corporation for Peritoneal Dialysis Business 136
10.1.2 Fresenius Medical Care Acquires Hema Metrics’ Crit-Line System Business 136
10.1.3 Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro 136
10.2 Partnership Deals, 2008-2012 137
10.2.1 Nephros Enters into Licensing Agreement with Bellco 137
10.2.2 Interface Biologics Enters Into Licensing Agreement with Fresenius Medical Care 137
10.2.3 Fresenius Medical Care Enters into Long-Term Distribution Agreement with Nikkiso 138
10.3 Asset Transaction, 2008-2012 138
10.3.1 Xcorporeal and National Quality Care to Sell Assets to Fresenius USA 138

11 Appendix 139
11.1 Market Definitions 139
11.1.1 Renal Dialysis Equipment 139
11.1.2 Hemodialysis Machines 139
11.1.3 Peritoneal Dialysis Solutions 140
11.1.4 Continuous Renal Replacement Therapy (CRRT) Machines 140
11.1.5 Dialysis Accessories 140
11.2 Abbreviations (in alphabetical order) 140
11.3 Sources 142
11.4 Research Methodology 147
11.4.1 Secondary Research 147
11.4.2 Primary Research 147
11.4.3 Models 148
11.4.4 Forecasts 148
11.4.5 Expert Panel 148
11.5 GlobalData Consulting 148
11.6 Contact Us 148
11.7 Disclaimer 149

List of Tables


Table 1: Prevalence of Co-morbidities by CRF Stage in the US Population Age >20 Years; NHANES, 1999-2006 16
Table 2: Causes of ESRD, the US, 2008 17
Table 3: Incident ESRD Patients by Primary Cause of Diagnosis, Australia, 2007-2010 18
Table 4: Number of ESRD Patients by Country, 2006-2009 19
Table 5: ESRD Incidence and Prevalence Rate (per Million Population) by Country, 2009 20
Table 6: Population-Based Studies of the Prevalence of Chronic Renal Failure in the US 21
Table 7: Incidence of ESRD, Canada, 2006-2009 22
Table 8: Population-Based Studies of CRF Prevalence, Europe 22
Table 9: Annual Intake of New Patients and Incidence of ESRD, Australia, 2006-2010 23
Table 10: ESRD Global Outlook: Number of Dialysis and Kidney Transplant Patients, 2010 24
Table 11: Dialysis Patient Population by Country, 2006-2009 25
Table 12: Dialysis Patients Per 100,000 Population by Country, 2006-2009 26
Table 13: Comparison of CAPD and CCPD Patient Numbers, Global, 2000-2010 34
Table 14: Percent Distribution of Prevalent Dialysis Patients, by Modality, by Country, 2009 36
Table 15: Renal Dialysis Equipment Market, Global, Revenue ($bn), 2004-2011 37
Table 16: Renal Dialysis Equipment Market, Global, Revenue ($bn), 2011-2018 38
Table 17: Percent Prevalence of Dialysis Patients Using Home-based Dialysis Therapies (Home Hemodialysis and Peritoneal Dialysis), 2009 39
Table 18: Pipeline of Wearable, Portable Dialysis Machines 43
Table 19: Diabetes as a Cause of ESRD, Weighted Percentage, by Country, 2002-2010 46
Table 20: Diabetes Prevalence (%) and Patient Population, by Country, 2011 - 2030 47
Table 21: Annual Growth Rate of Total World Population and Elderly Population Aged 60 or Above, Global, 1950-2050 49
Table 22: Observational Studies Favoring Shorter and More Frequent Hemodialysis Sessions 50
Table 23: Number of Dialysis Centers, Global, 2005-2011 52
Table 24: Number of Kidney Transplantation Procedures by Country, 2006-2009 54
Table 25: Functioning Kidney Transplants, Patients per 100,000 Population, by Country, 2006-2009 55
Table 26: Hemodialysis Machines Market, Global, Revenue ($m), 2004-2011 59
Table 27: Hemodialysis Machines Market, Global, Revenue ($m) , 2011-2018 60
Table 28: Possible Complications of Hemodialysis 62
Table 29: Peritoneal Dialysis Solutions Market, Global, Revenue ($bn), 2004-2011 63
Table 30: Peritoneal Dialysis Solutions Market, Global, Revenue ($bn), 2011-2018 64
Table 31: Possible Complications of Peritoneal Dialysis and Their Causes 68
Table 32: Continuous Renal Replacement Therapy Machines Market, Global, Revenue ($m), 2004-2011 70
Table 33: Continuous Renal Replacement Therapy Machines Market, Global, Revenue ($m), 2011-2018 71
Table 34: Dialysis Accessories Market, Global, Revenue ($m), 2004-2011 74
Table 35: Dialysis Accessories Market, Global, Revenue ($m), 2011-2018 75
Table 36: Disadvantages of Dialysis Accessories 76
Table 37: Renal Dialysis Equipment Market, The US, Revenue ($m), 2004-2011 77
Table 38: Renal Dialysis Equipment Market, The US, Revenue ($m), 2011-2018 79
Table 39: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2004-2011 80
Table 40: Prevalent ESRD Patient Numbers by Treatment Modality, Canada, 2000-2009 81
Table 41: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2011-2018 82
Table 42: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2004-2011 83
Table 43: Prevalence Rate (per Million Population), by Treatment Modality, the UK, 2005-2009 83
Table 44: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2011-2018 84
Table 45: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2004-2011 85
Table 46: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2011-2018 86
Table 47: Renal Dialysis Equipment Market, France, Revenue ($m), 2004-2011 87
Table 48: Renal Dialysis Equipment Market, France, Revenue ($m), 2011-2018 88
Table 49: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2004-2011 89
Table 50: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2011-2018 90
Table 51: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2004-2011 91
Table 52: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2011-2018 92
Table 53: Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
Table 54: Renal Dialysis Equipment Market, Japan, Revenue ($m), 2011-2018 95
Table 55: Renal Dialysis Equipment Market, China, Revenue ($m), 2004-2011 96
Table 56: Renal Dialysis Equipment Market, China, Revenue ($m), 2011-2018 97
Table 57: Renal Dialysis Equipment Market, India, Revenue ($m), 2004-2011 98
Table 58: Renal Dialysis Equipment Market, India, Revenue ($m), 2011-2018 99
Table 59: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2004-2011 100
Table 60: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2011-2018 101
Table 61: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2004-2011 102
Table 62: Dialysis Patients, Brazil, 2000-2010 103
Table 63: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2011-2018 104
Table 64: Renal Dialysis Equipment Market, Global, Company Share (%), 2011 105
Table 65: Fresenius Medical Care, Key Marketed Products, 2012 107
Table 66: Baxter International, Key Marketed Products, 2012 111
Table 67: Gambro, Key Marketed Products, 2012 113
Table 68: B. Braun Melsungen, Key Marketed Products, 2012 115
Table 69: Nipro Corporation, Key Marketed Products, 2012 116
Table 70: Hemodialysis Machines and Equipment, Pipeline Products, 2011 118
Table 71: AFE System, Product Status, 2012 119
Table 72: Ambulatory Wearable Device, Product Status, 2012 119
Table 73: Blood Purification Technologies Wearable Artificial Kidney, Product Status, 2012 120
Table 74: Hemova Port Device, Product Status, 2012 120
Table 75: Lifeline TEBV - AV Shunt, Product Status, 2012 121
Table 76: Neutrolin, Product Status, 2012 121
Table 77: Nocturnal Home Hemodialysis System, Product Status, 2012 122
Table 78: Optiflow Vascular Anastomotic System, Product Status, 2012 122
Table 79: Pediatric Renal Dialysis Machine, Product Status, 2012 123
Table 80: Phraxis InterGraft, Product Status, 2012 123
Table 81: Prolong AV Graft, Product Status, 2012 124
Table 82: SelfCare+, Product Status, 2012 124
Table 83: Theralite, Product Status, 2012 125
Table 84: Thixotropic Gel, Product Status, 2012 125
Table 85: Peritoneal Dialysis Equipment and Accessories, Pipeline Products Summary, 2011 126
Table 86: AWAK, Product Status, 2012 126
Table 87: Non PVC CAPD, Product Status, 2012 127
Table 88: Renal Expres, Product Status, 2012 128
Table 89: Dialysis Accessories, Pipeline Products Summary, 2011 128
Table 90: Artificial Hemodialysis Access Graft, Product Status, 2012 129
Table 91: ASPIRE Hemodialysis, Product Status, 2012 129
Table 92: Biologic Vascular Graft, Product Status, 2012 129
Table 93: ClearGuard HD, Product Status, 2012 130
Table 94: CMA 107 Microdialysis Pump, Product Status, 2012 130
Table 95: CreatiVasc Hemoaccess Valve System, Product Status, 2012 131
Table 96: dCELL Arterial-Vascular Graft, Product Status, 2012 131
Table 97: NexSite Hemodialysis Catheter, Product Status, 2012 132
Table 98: Percutaneous Implant Tool, Product Status, 2012 132
Table 99: Renaflo II Hemofilter, Product Status, 2012 133
Table 100: Reversus Hemodialysis Catheter, Product Status, 2012 133
Table 101: Selective Cytopheretic Device, Product Status, 2012 134
Table 102: SAFETOUCH AVF Needle, Product Status, 2012 134
Table 103: NexSite Hemodialysis Catheter, Product Status, 2012 135
Table 104: Renal Dialysis Equipment Market, Global, Acquisition Deals, 2008-2012 136
Table 105: Global Renal Dialysis Equipment Market, Partnership Deals, 2008-2012 137
Table 106: Global Renal Dialysis Equipment Market, Asset Transaction, 2008-2012 138

List of Figures


Figure 1: Types of Renal Failure 11
Figure 2: Stages of Chronic Renal Failure 12
Figure 3: Risk Factors for Chronic Renal Failure 13
Figure 4: Signs and Symptoms of Chronic Renal Failure 14
Figure 5: Prevalence of Co-Morbidities by CRF Stage in the US Population Aged >20 Years; NHANES, 1999-2006 16
Figure 6: Global Incidence and Prevalence of ESRD by Country, 2009 20
Figure 7: Standard Home Hemodialysis-Advantages and Disadvantages 28
Figure 8: Nocturnal Home Hemodialysis- Advantages and Disadvantages 29
Figure 9: Short Daily Home Hemodialysis - Advantages and Disadvantages 29
Figure 10: Advantages and Disadvantages of Home Hemodialysis and In-Center Hemodialysis 30
Figure 11: Advantages and Disadvantages of Continuous Ambulatory Peritoneal Dialysis and Continuous Cyclic Peritoneal Dialysis 33
Figure 12: Comparison of Global Patient Preferences for CAPD and CCPD, 2000-2010 34
Figure 13: Advantages and Disadvantages of Hemodialysis and Peritoneal Dialysis 35
Figure 14: Percent Distribution of Prevalent Dialysis Patients by Modality and Country, 2009 36
Figure 15: Global Renal Dialysis Equipment Market, Revenue ($bn), 2004-2011 37
Figure 16: Global Renal Dialysis Equipment Market, Revenue ($bn), 2011-2018 38
Figure 17: Suitability Criteria for Home Hemodialysis 39
Figure 18: Benefits of Home Hemodialysis 40
Figure 19: Home Hemodialysis Usage Over the Years 41
Figure 20: Medicare Reimbursement for Home Hemodialysis Services and Supplies 43
Figure 21: Global Renal Dialysis Equipment Market Dynamics, Drivers and Barriers 44
Figure 22: DOPPS:Diabetes as a Cause of ESRD, Weighted Percentage by Country, 2002-2010 45
Figure 23: Diabetes Prevalence (%) by Country, 2011 47
Figure 24: Functional and Structural Changes in the Kidneys of the Elderly 48
Figure 25: Annual Growth Rate of Total World Population and Global Population >Age 60, 1950-2050 49
Figure 26: Global Number of Dialysis Centers, 2005-2011 52
Figure 27: Advantages of Kidney Transplantation 53
Figure 28: Patients with Functioning Kidney Transplants per 100,000 Population by Country, 2006-2009 55
Figure 29: Benefits of the UCSF Implantable Artificial Kidney 56
Figure 30: Market Segmentation of Renal Dialysis Equipment, 2011 58
Figure 31: Global Hemodialysis Machines Market, Revenue ($m), 2004-2011 59
Figure 32: Global Hemodialysis Machines Market, Revenue ($m) , 2011-2018 60
Figure 33: Global Peritoneal Dialysis Solutions Market, Revenue ($bn), 2004-2011 63
Figure 34: Global Peritoneal Dialysis Solutions Market, Revenue ($bn), 2011-2018 64
Figure 35: Characteristics of Commercially Available Multibag PD Solutions 66
Figure 36: Characteristics of Commercially Available Single-Bag PD solutions 66
Figure 37: Continuous Renal Replacement Therapies Used in Intensive Care Units 69
Figure 38: Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), 2004-2011 70
Figure 39: Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), 2011-2018 71
Figure 40: Short- and Long-Term Benefits of Continuous Renal Replacement Therapy 72
Figure 41: Global Dialysis Accessories Market, Revenue ($m), 2004-2011 73
Figure 42: Global Dialysis Accessories Market, Revenue ($m), 2011-2018 74
Figure 43: Renal Dialysis Equipment Market, The US, Revenue ($m), 2004-2011 77
Figure 44: Renal Dialysis Equipment Market, The US, Revenue ($m), 2011-2018 78
Figure 45: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2004-2011 80
Figure 46: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2011-2018 81
Figure 47: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2004-2011 82
Figure 48: Prevalence Rate (per Million Population) by Treatment Modality, the UK, 2005-2009 83
Figure 49: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2011-2018 84
Figure 50: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2004-2011 85
Figure 51: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2011-2018 86
Figure 52: Renal Dialysis Equipment Market, France, Revenue ($m), 2004-2011 87
Figure 53: Renal Dialysis Equipment Market, France, Revenue ($m), 2011-2018 88
Figure 54: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2004-2011 89
Figure 55: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2011-2018 90
Figure 56: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2004-2011 91
Figure 57: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2011-2018 92
Figure 58: Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
Figure 59: Renal Dialysis Equipment Market, Japan, Revenue ($m), 2011-2018 94
Figure 60: Renal Dialysis Equipment Market, China, Revenue ($m), 2004-2011 96
Figure 61: Renal Dialysis Equipment Market, China, Revenue ($m), 2011-2018 97
Figure 62: Renal Dialysis Equipment Market, India, Revenue ($m), 2004-2011 98
Figure 63: Renal Dialysis Equipment Market, India, Revenue ($m), 2011-2018 99
Figure 64: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2004-2011 100
Figure 65: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2011-2018 101
Figure 66: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2004-2011 102
Figure 67: Number of Patients on Dialysis, Brazil, 2000-2010 103
Figure 68: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2011-2018 104
Figure 69: Global Renal Dialysis Equipment Market , Company Share (%), 2011 105
Figure 70: Global Renal Dialysis Equipment Market, Opportunities and Risks, 2012 106
Figure 71: Fresenius Medical Care, Internal Factors Evaluation 108
Figure 72: Baxter International, Internal Factors Evaluation 111
Figure 73: Gambro, Internal Factors Evaluation 113
Figure 74: B. Braun Melsungen, Internal Factors Evaluation 115
Figure 75: Nipro Corporation, Internal Factors Evaluation 117
Figure 76: Global Renal Dialysis Equipment Market, Pipeline Products by Stage, 2012 118

Upcoming Reports:

Rubella Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Rubella or German measles is a contagious and acute viral infection caused by the rubella virus. Generally, rubella infection occurs most often in young adults and children. While the rubella infection is typically mild in children, this disease has serious consequences in pregnant women causing congenital defects and fetal death. Some of the diagnostic testing techniques usually adopted for the diagnosis of rubella are as follows: Clinical evaluation Serological testing Immunoassays Monoclonal antibodies Latex slide agglutination test Flow cytometry...
Exocrine Pancreatic Insufficiency Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
By - Transparency Market Research
The pancreas, a vital organ plays an important role of producing and secreting key digestive enzymes and hormones required for regulating glucose in the human body. Exocrine pancreatic insufficiency (EPI) is characterized by lack of digestive enzymes normally secreted from the pancreas into the digestive track leading to inappropriate digestion of food. Primarily, these digestive enzymes include proteases for protein digestion, lipases for fat digestion and amylases for starch digestion. In addition to these enzymes, several other key digestive enzymes, coenzymes and cofactors are also...
Greece: chickpeas market
By - Williams and Marshal Strategy
ose of the report is to describe the state of the chickpeas market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...